Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations
- 31 August 2004
- journal article
- review article
- Published by Elsevier in Clinical Immunology
- Vol. 112 (2) , 190-199
- https://doi.org/10.1016/j.clim.2004.02.018
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- A role for Toll in autoimmunityNature Immunology, 2002
- Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus‐derived peptide cause thrombosis and activation of endothelial cells in vivoArthritis & Rheumatism, 2002
- Apoptosis and the Antiphospholipid SyndromeJournal of Autoimmunity, 2000
- New Developments in Viral Peptides and APL InductionJournal of Autoimmunity, 2000
- Analysis of T cell responses to the β2-glycoprotein I-derived peptide library in patients with anti-β2-glycoprotein I antibody-associated autoimmunityHuman Immunology, 2000
- Helicobacter pyloriEuropean Journal of Gastroenterology & Hepatology, 1999
- Apoptotic cell clearance in systemic lupus erythematosus: II. Role of ?2-glycoprotein IArthritis & Rheumatism, 1998
- Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expressionArthritis & Rheumatism, 1998
- Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human β2 glycoprotein 1 or anticardiolipin antibodies aloneClinical and Experimental Immunology, 1993
- Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic networkClinical Immunology and Immunopathology, 1992